Sg Americas Securities, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$1.39 - $2.21 $14,735 - $23,428	-10,601 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.27 - $3.42 $121,605 - $327,471	-95,752 Reduced 90.03%	10,601 $21,000
Q4 2020 Feb 04, 2021	SELL	$0.94 - $1.89 $1.05 Million - $2.12 Million	-1,121,753 Reduced 91.34%	106,353 $133,000
Q3 2020 Nov 09, 2020	BUY	$1.5 - $9.38 $1.71 Million - $10.7 Million	1,137,258 Added 1251.83%	1,228,106 $2.21 Million
Q2 2020 Jul 20, 2020	BUY	$4.79 - $8.39 $374,314 - $655,636	78,145 Added 615.17%	90,848 $762,000
Q1 2020 Apr 30, 2020	BUY	$3.44 - $7.21 $43,698 - $91,588	12,703 New	12,703 $67,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $739M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.